Selecta Biosciences (NASDAQ:SELB) was downgraded by research analysts at William Blair to a “hold” rating in a report released on Thursday, AnalystRatings.com reports. Other equities analysts have also issued research reports about the company. BidaskClub raised Selecta Biosciences from a “sell” rating to a “hold” rating in a research note on Wednesday, September 16th. ValuEngine […]
